Diagnosing Omenn syndrome

2021 ◽  
Author(s):  
Louise Cutts ◽  
Arti Bakshi ◽  
Maeve Walsh ◽  
Richard Parslew ◽  
Karen Eustace
Keyword(s):  
Immunobiology ◽  
2021 ◽  
pp. 152090
Author(s):  
Ibtihal Benhsaien ◽  
Soukaina Essadssi ◽  
Lamiae Elkhattabi ◽  
Amina Bakhchane ◽  
Houria Abdelghaffar ◽  
...  

Author(s):  
Andrea Estébanez ◽  
Jaime Verdú‐Amorós ◽  
Esmeralda Silva ◽  
Rebeca Velasco ◽  
Ana Cuesta ◽  
...  

2005 ◽  
Vol 75 (5) ◽  
pp. 441-444 ◽  
Author(s):  
Daisuke Tomizawa ◽  
Yuki Aoki ◽  
Masayuki Nagasawa ◽  
Tomohiro Morio ◽  
Michiko Kajiwara ◽  
...  

2008 ◽  
Vol 121 (2) ◽  
pp. S89-S89
Author(s):  
O DELMONTE ◽  
W SHEEHAN ◽  
D MILLER ◽  
A ROBERTS ◽  
F BONILLA ◽  
...  
Keyword(s):  

Blood ◽  
2012 ◽  
Vol 120 (5) ◽  
pp. 1005-1014 ◽  
Author(s):  
Veronica Marrella ◽  
Pietro L. Poliani ◽  
Elena Fontana ◽  
Anna Casati ◽  
Virginia Maina ◽  
...  

Abstract Omenn syndrome (OS) is an atypical primary immunodeficiency characterized by severe autoimmunity because of activated T cells infiltrating target organs. The impaired recombinase activity in OS severely affects expression of the pre-T-cell receptor complex in immature thymocytes, which is crucial for an efficient development of the thymic epithelial component. Anti-CD3ε monoclonal antibody (mAb) treatment in RAG2−/− mice was previously shown to mimic pre-TCR signaling promoting thymic expansion. Here we show the effect of anti-CD3ε mAb administration in the RAG2R229Q mouse model, which closely recapitulates human OS. These animals, in spite of the inability to induce the autoimmune regulator, displayed a significant amelioration in thymic epithelial compartment and an important reduction of peripheral T-cell activation and tissue infiltration. Furthermore, by injecting a high number of RAG2R229Q progenitors into RAG2−/− animals previously conditioned with anti-CD3ε mAb, we detected autoimmune regulator expression together with the absence of peripheral immunopathology. These observations indicate that improving epithelial thymic function might ameliorate the detrimental behavior of the cell-autonomous RAG defect. Our data provide important therapeutic proof of concept for future clinical applications of anti-CD3ε mAb treatment in severe combined immunodeficiency forms characterized by poor thymus function and autoimmunity.


2017 ◽  
Vol 137 (10) ◽  
pp. B5
Author(s):  
M. Wat ◽  
A. Olicker ◽  
H. Meyerson ◽  
K Ruda Wessell ◽  
S. Nedorost ◽  
...  
Keyword(s):  

2016 ◽  
Vol 8 (5) ◽  
pp. 379-384 ◽  
Author(s):  
Ezgi Ulusoy ◽  
Neslihan Edeer Karaca ◽  
Elif Azarsiz ◽  
Afig Berdeli ◽  
Guzide Aksu ◽  
...  

2009 ◽  
Vol 13 (2) ◽  
pp. 244-250 ◽  
Author(s):  
Tanja A. Gruber ◽  
Ami J. Shah ◽  
Michelle Hernandez ◽  
Gay M. Crooks ◽  
Hisham Abdel-Azim ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document